
### [NCIT:C40077](http://purl.obolibrary.org/obo/NCIT_C40077)
**Label:** Malignant Ovarian Clear Cell Tumor

**Subclasses:** [NCIT:C40078](http://purl.obolibrary.org/obo/NCIT_C40078) (Ovarian Clear Cell Adenocarcinoma), [NCIT:C40079](http://purl.obolibrary.org/obo/NCIT_C40079) (Ovarian Clear Cell Adenocarcinofibroma), [NCIT:C7980](http://purl.obolibrary.org/obo/NCIT_C7980) (Ovarian Clear Cell Cystadenocarcinoma), 

**Class expressions from DL-Learner:**

- Thing 52.15%
- [NCIT:C36815](http://purl.obolibrary.org/obo/NCIT_C36815) (Adenocarcinoma Clear Cell) 42.50%
- [NCIT:C36815](http://purl.obolibrary.org/obo/NCIT_C36815) (Adenocarcinoma Clear Cell) and (not ([NCIT:C39961](http://purl.obolibrary.org/obo/NCIT_C39961) (Penile Basal Cell Carcinoma))) 42.50%
- [NCIT:C36815](http://purl.obolibrary.org/obo/NCIT_C36815) (Adenocarcinoma Clear Cell) and (not ([NCIT:C39959](http://purl.obolibrary.org/obo/NCIT_C39959) (Mixed Squamous Cell Carcinoma of the Penis))) 42.50%
- [NCIT:C36815](http://purl.obolibrary.org/obo/NCIT_C36815) (Adenocarcinoma Clear Cell) and (not ([NCIT:C39957](http://purl.obolibrary.org/obo/NCIT_C39957) (Epididymal Adenocarcinoma))) 42.50%
- [NCIT:C36815](http://purl.obolibrary.org/obo/NCIT_C36815) (Adenocarcinoma Clear Cell) and (not ([NCIT:C39956](http://purl.obolibrary.org/obo/NCIT_C39956) (Rete Testis Adenoma))) 42.50%
- [NCIT:C36815](http://purl.obolibrary.org/obo/NCIT_C36815) (Adenocarcinoma Clear Cell) and (not ([NCIT:C3994](http://purl.obolibrary.org/obo/NCIT_C3994) (Stage IV Colon Cancer AJCC v6))) 42.50%
- [NCIT:C36815](http://purl.obolibrary.org/obo/NCIT_C36815) (Adenocarcinoma Clear Cell) and (not ([NCIT:C3993](http://purl.obolibrary.org/obo/NCIT_C3993) (Stage II Colon Cancer AJCC v6))) 42.50%
- [NCIT:C36815](http://purl.obolibrary.org/obo/NCIT_C36815) (Adenocarcinoma Clear Cell) and (not ([NCIT:C39914](http://purl.obolibrary.org/obo/NCIT_C39914) (Gain of Chromosome 12p))) 42.50%
- [NCIT:C36815](http://purl.obolibrary.org/obo/NCIT_C36815) (Adenocarcinoma Clear Cell) and (not ([NCIT:C3991](http://purl.obolibrary.org/obo/NCIT_C3991) (Thrombocytopenia Due to Immune Destruction))) 42.50%
- [NCIT:C36815](http://purl.obolibrary.org/obo/NCIT_C36815) (Adenocarcinoma Clear Cell) and (not ([NCIT:C39909](http://purl.obolibrary.org/obo/NCIT_C39909) (Gain of Chromosome 18q))) 42.50%
- [NCIT:C36815](http://purl.obolibrary.org/obo/NCIT_C36815) (Adenocarcinoma Clear Cell) and (not ([NCIT:C39907](http://purl.obolibrary.org/obo/NCIT_C39907) (Seminal Vesicle Cystadenoma))) 42.50%
- [NCIT:C36815](http://purl.obolibrary.org/obo/NCIT_C36815) (Adenocarcinoma Clear Cell) and (not ([NCIT:C39906](http://purl.obolibrary.org/obo/NCIT_C39906) (Seminal Vesicle Adenocarcinoma))) 42.50%
- [NCIT:C36815](http://purl.obolibrary.org/obo/NCIT_C36815) (Adenocarcinoma Clear Cell) and (not ([NCIT:C39905](http://purl.obolibrary.org/obo/NCIT_C39905) (Prostate Stromal Proliferation of Uncertain Malignant Potential))) 42.50%
- [NCIT:C36815](http://purl.obolibrary.org/obo/NCIT_C36815) (Adenocarcinoma Clear Cell) and (not ([NCIT:C39903](http://purl.obolibrary.org/obo/NCIT_C39903) (Prostate Adenocarcinoma with Focal Neuroendocrine Differentiation))) 42.50%


